Global PET Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 114
Published Date: 23 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global PET Radiopharmaceuticals market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the PET Radiopharmaceuticals industry chain, the market status of Oncology (F-18, Ru-82), Cardiology (F-18, Ru-82), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of PET Radiopharmaceuticals.
Regionally, the report analyzes the PET Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global PET Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the PET Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the PET Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., F-18, Ru-82).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the PET Radiopharmaceuticals market.
Regional Analysis: The report involves examining the PET Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the PET Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to PET Radiopharmaceuticals:
Company Analysis: Report covers individual PET Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards PET Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to PET Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in PET Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the PET Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
PET Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
F-18
Ru-82
Others
Market segment by Application
Oncology
Cardiology
Neurology
Others
Major players covered
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PET Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PET Radiopharmaceuticals, with price, sales, revenue and global market share of PET Radiopharmaceuticals from 2019 to 2024.
Chapter 3, the PET Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PET Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and PET Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PET Radiopharmaceuticals.
Chapter 14 and 15, to describe PET Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of PET Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PET Radiopharmaceuticals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 F-18
1.3.3 Ru-82
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global PET Radiopharmaceuticals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Neurology
1.4.5 Others
1.5 Global PET Radiopharmaceuticals Market Size & Forecast
1.5.1 Global PET Radiopharmaceuticals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global PET Radiopharmaceuticals Sales Quantity (2019-2030)
1.5.3 Global PET Radiopharmaceuticals Average Price (2019-2030)
2.1 Cardinal Health Inc. (U.S.)
2.1.1 Cardinal Health Inc. (U.S.) Details
2.1.2 Cardinal Health Inc. (U.S.) Major Business
2.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services
2.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Cardinal Health Inc. (U.S.) Recent Developments/Updates
2.2 Mallinckrodt plc (Ireland)
2.2.1 Mallinckrodt plc (Ireland) Details
2.2.2 Mallinckrodt plc (Ireland) Major Business
2.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services
2.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Mallinckrodt plc (Ireland) Recent Developments/Updates
2.3 GE Healthcare (U.K.)
2.3.1 GE Healthcare (U.K.) Details
2.3.2 GE Healthcare (U.K.) Major Business
2.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services
2.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GE Healthcare (U.K.) Recent Developments/Updates
2.4 Lantheus Medical Imaging, Inc. (U.S.)
2.4.1 Lantheus Medical Imaging, Inc. (U.S.) Details
2.4.2 Lantheus Medical Imaging, Inc. (U.S.) Major Business
2.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services
2.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates
2.5 Bayer AG (Germany)
2.5.1 Bayer AG (Germany) Details
2.5.2 Bayer AG (Germany) Major Business
2.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Product and Services
2.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer AG (Germany) Recent Developments/Updates
2.6 Bracco Imaging S.p.A (Italy)
2.6.1 Bracco Imaging S.p.A (Italy) Details
2.6.2 Bracco Imaging S.p.A (Italy) Major Business
2.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services
2.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bracco Imaging S.p.A (Italy) Recent Developments/Updates
2.7 Eczacibasi-Monrol Nuclear Products (Turkey)
2.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Details
2.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Major Business
2.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services
2.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates
2.8 Nordion, Inc. (Canada)
2.8.1 Nordion, Inc. (Canada) Details
2.8.2 Nordion, Inc. (Canada) Major Business
2.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services
2.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Nordion, Inc. (Canada) Recent Developments/Updates
2.9 Advanced Accelerator Applications S.A. (France)
2.9.1 Advanced Accelerator Applications S.A. (France) Details
2.9.2 Advanced Accelerator Applications S.A. (France) Major Business
2.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services
2.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments/Updates
2.10 IBA Molecular Imaging (Belgium)
2.10.1 IBA Molecular Imaging (Belgium) Details
2.10.2 IBA Molecular Imaging (Belgium) Major Business
2.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services
2.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 IBA Molecular Imaging (Belgium) Recent Developments/Updates
3.1 Global PET Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024)
3.2 Global PET Radiopharmaceuticals Revenue by Manufacturer (2019-2024)
3.3 Global PET Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of PET Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 PET Radiopharmaceuticals Manufacturer Market Share in 2023
3.4.2 Top 6 PET Radiopharmaceuticals Manufacturer Market Share in 2023
3.5 PET Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 PET Radiopharmaceuticals Market: Region Footprint
3.5.2 PET Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 PET Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global PET Radiopharmaceuticals Market Size by Region
4.1.1 Global PET Radiopharmaceuticals Sales Quantity by Region (2019-2030)
4.1.2 Global PET Radiopharmaceuticals Consumption Value by Region (2019-2030)
4.1.3 Global PET Radiopharmaceuticals Average Price by Region (2019-2030)
4.2 North America PET Radiopharmaceuticals Consumption Value (2019-2030)
4.3 Europe PET Radiopharmaceuticals Consumption Value (2019-2030)
4.4 Asia-Pacific PET Radiopharmaceuticals Consumption Value (2019-2030)
4.5 South America PET Radiopharmaceuticals Consumption Value (2019-2030)
4.6 Middle East and Africa PET Radiopharmaceuticals Consumption Value (2019-2030)
5.1 Global PET Radiopharmaceuticals Sales Quantity by Type (2019-2030)
5.2 Global PET Radiopharmaceuticals Consumption Value by Type (2019-2030)
5.3 Global PET Radiopharmaceuticals Average Price by Type (2019-2030)
6.1 Global PET Radiopharmaceuticals Sales Quantity by Application (2019-2030)
6.2 Global PET Radiopharmaceuticals Consumption Value by Application (2019-2030)
6.3 Global PET Radiopharmaceuticals Average Price by Application (2019-2030)
7.1 North America PET Radiopharmaceuticals Sales Quantity by Type (2019-2030)
7.2 North America PET Radiopharmaceuticals Sales Quantity by Application (2019-2030)
7.3 North America PET Radiopharmaceuticals Market Size by Country
7.3.1 North America PET Radiopharmaceuticals Sales Quantity by Country (2019-2030)
7.3.2 North America PET Radiopharmaceuticals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe PET Radiopharmaceuticals Sales Quantity by Type (2019-2030)
8.2 Europe PET Radiopharmaceuticals Sales Quantity by Application (2019-2030)
8.3 Europe PET Radiopharmaceuticals Market Size by Country
8.3.1 Europe PET Radiopharmaceuticals Sales Quantity by Country (2019-2030)
8.3.2 Europe PET Radiopharmaceuticals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific PET Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific PET Radiopharmaceuticals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America PET Radiopharmaceuticals Sales Quantity by Type (2019-2030)
10.2 South America PET Radiopharmaceuticals Sales Quantity by Application (2019-2030)
10.3 South America PET Radiopharmaceuticals Market Size by Country
10.3.1 South America PET Radiopharmaceuticals Sales Quantity by Country (2019-2030)
10.3.2 South America PET Radiopharmaceuticals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa PET Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa PET Radiopharmaceuticals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 PET Radiopharmaceuticals Market Drivers
12.2 PET Radiopharmaceuticals Market Restraints
12.3 PET Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of PET Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of PET Radiopharmaceuticals
13.3 PET Radiopharmaceuticals Production Process
13.4 PET Radiopharmaceuticals Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PET Radiopharmaceuticals Typical Distributors
14.3 PET Radiopharmaceuticals Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global PET Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global PET Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Cardinal Health Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 4. Cardinal Health Inc. (U.S.) Major Business
Table 5. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product and Services
Table 6. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Cardinal Health Inc. (U.S.) Recent Developments/Updates
Table 8. Mallinckrodt plc (Ireland) Basic Information, Manufacturing Base and Competitors
Table 9. Mallinckrodt plc (Ireland) Major Business
Table 10. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Services
Table 11. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Mallinckrodt plc (Ireland) Recent Developments/Updates
Table 13. GE Healthcare (U.K.) Basic Information, Manufacturing Base and Competitors
Table 14. GE Healthcare (U.K.) Major Business
Table 15. GE Healthcare (U.K.) PET Radiopharmaceuticals Product and Services
Table 16. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GE Healthcare (U.K.) Recent Developments/Updates
Table 18. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 19. Lantheus Medical Imaging, Inc. (U.S.) Major Business
Table 20. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product and Services
Table 21. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates
Table 23. Bayer AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 24. Bayer AG (Germany) Major Business
Table 25. Bayer AG (Germany) PET Radiopharmaceuticals Product and Services
Table 26. Bayer AG (Germany) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bayer AG (Germany) Recent Developments/Updates
Table 28. Bracco Imaging S.p.A (Italy) Basic Information, Manufacturing Base and Competitors
Table 29. Bracco Imaging S.p.A (Italy) Major Business
Table 30. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product and Services
Table 31. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bracco Imaging S.p.A (Italy) Recent Developments/Updates
Table 33. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, Manufacturing Base and Competitors
Table 34. Eczacibasi-Monrol Nuclear Products (Turkey) Major Business
Table 35. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Services
Table 36. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates
Table 38. Nordion, Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table 39. Nordion, Inc. (Canada) Major Business
Table 40. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product and Services
Table 41. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Nordion, Inc. (Canada) Recent Developments/Updates
Table 43. Advanced Accelerator Applications S.A. (France) Basic Information, Manufacturing Base and Competitors
Table 44. Advanced Accelerator Applications S.A. (France) Major Business
Table 45. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product and Services
Table 46. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Advanced Accelerator Applications S.A. (France) Recent Developments/Updates
Table 48. IBA Molecular Imaging (Belgium) Basic Information, Manufacturing Base and Competitors
Table 49. IBA Molecular Imaging (Belgium) Major Business
Table 50. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Services
Table 51. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. IBA Molecular Imaging (Belgium) Recent Developments/Updates
Table 53. Global PET Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 54. Global PET Radiopharmaceuticals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global PET Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 56. Market Position of Manufacturers in PET Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and PET Radiopharmaceuticals Production Site of Key Manufacturer
Table 58. PET Radiopharmaceuticals Market: Company Product Type Footprint
Table 59. PET Radiopharmaceuticals Market: Company Product Application Footprint
Table 60. PET Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 61. PET Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global PET Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Pcs)
Table 63. Global PET Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Pcs)
Table 64. Global PET Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global PET Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global PET Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Pcs)
Table 67. Global PET Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Pcs)
Table 68. Global PET Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Pcs)
Table 69. Global PET Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Pcs)
Table 70. Global PET Radiopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global PET Radiopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global PET Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Pcs)
Table 73. Global PET Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Pcs)
Table 74. Global PET Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Pcs)
Table 75. Global PET Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Pcs)
Table 76. Global PET Radiopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global PET Radiopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global PET Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Pcs)
Table 79. Global PET Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Pcs)
Table 80. North America PET Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Pcs)
Table 81. North America PET Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Pcs)
Table 82. North America PET Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Pcs)
Table 83. North America PET Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Pcs)
Table 84. North America PET Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Pcs)
Table 85. North America PET Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Pcs)
Table 86. North America PET Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America PET Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe PET Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Pcs)
Table 89. Europe PET Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Pcs)
Table 90. Europe PET Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Pcs)
Table 91. Europe PET Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Pcs)
Table 92. Europe PET Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Pcs)
Table 93. Europe PET Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Pcs)
Table 94. Europe PET Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe PET Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Pcs)
Table 97. Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Pcs)
Table 98. Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Pcs)
Table 99. Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Pcs)
Table 100. Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Pcs)
Table 101. Asia-Pacific PET Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Pcs)
Table 102. Asia-Pacific PET Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific PET Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America PET Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Pcs)
Table 105. South America PET Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Pcs)
Table 106. South America PET Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Pcs)
Table 107. South America PET Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Pcs)
Table 108. South America PET Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Pcs)
Table 109. South America PET Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Pcs)
Table 110. South America PET Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America PET Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Pcs)
Table 113. Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Pcs)
Table 114. Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Pcs)
Table 115. Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Pcs)
Table 116. Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Pcs)
Table 117. Middle East & Africa PET Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Pcs)
Table 118. Middle East & Africa PET Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa PET Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 120. PET Radiopharmaceuticals Raw Material
Table 121. Key Manufacturers of PET Radiopharmaceuticals Raw Materials
Table 122. PET Radiopharmaceuticals Typical Distributors
Table 123. PET Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. PET Radiopharmaceuticals Picture
Figure 2. Global PET Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global PET Radiopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. F-18 Examples
Figure 5. Ru-82 Examples
Figure 6. Others Examples
Figure 7. Global PET Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global PET Radiopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 9. Oncology Examples
Figure 10. Cardiology Examples
Figure 11. Neurology Examples
Figure 12. Others Examples
Figure 13. Global PET Radiopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global PET Radiopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global PET Radiopharmaceuticals Sales Quantity (2019-2030) & (K Pcs)
Figure 16. Global PET Radiopharmaceuticals Average Price (2019-2030) & (USD/Pcs)
Figure 17. Global PET Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global PET Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of PET Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 PET Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 PET Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global PET Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global PET Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 24. North America PET Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe PET Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific PET Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 27. South America PET Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa PET Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 29. Global PET Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global PET Radiopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 31. Global PET Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Pcs)
Figure 32. Global PET Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global PET Radiopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 34. Global PET Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Pcs)
Figure 35. North America PET Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America PET Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America PET Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America PET Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 39. United States PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe PET Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe PET Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe PET Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe PET Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific PET Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific PET Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific PET Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific PET Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 55. China PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America PET Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America PET Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America PET Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America PET Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa PET Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa PET Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa PET Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa PET Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa PET Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. PET Radiopharmaceuticals Market Drivers
Figure 76. PET Radiopharmaceuticals Market Restraints
Figure 77. PET Radiopharmaceuticals Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals in 2023
Figure 80. Manufacturing Process Analysis of PET Radiopharmaceuticals
Figure 81. PET Radiopharmaceuticals Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Cardinal Health Inc. (U.S.) Mallinckrodt plc (Ireland) GE Healthcare (U.K.) Lantheus Medical Imaging, Inc. (U.S.) Bayer AG (Germany) Bracco Imaging S.p.A (Italy) Eczacibasi-Monrol Nuclear Products (Turkey) Nordion, Inc. (Canada) Advanced Accelerator Applications S.A. (France) IBA Molecular Imaging (Belgium)
Related Reports
17 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
